clinical trial · NCT04485039
Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders
SIGA Technologies·phase4·completed·n = 44
SmallpoxTecovirimatsevelamer carbonate oral tabletsucroferric oxyhydroxide chewable tabletcalcium acetate oral tabletLanthanum Carbonate Chewable Tablet
brief summary
An open-label, drug-drug interaction study with TPOXX and phosphate binders.
started
Jun 8, 2022
primary completion
Dec 15, 2022
completion
Apr 23, 2023
last updated
Dec 27, 2024
detailed description
A postmarketing open-label, 5 period crossover, drug-drug interaction study of orally administered TPOXX when coadministered with 4 different phosphate binders in healthy adult subjects.
official title
A Post-Marketing Open-Label, 5 Period Crossover, Drug-Drug Interaction Study of Orally Adminstered TPOXX When Co-administered With 4 Different Phosphate Binders in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol